MYOS stock forecast
Our latest prediction for MYOS RENS Technology, Inc.'s stock price was made on the April 25, 2018 when the stock price was at 1.24$.
In the short term (2weeks), MYOS's stock price should outperform the market by 4.30%. During that period the price should oscillate between -7.47% and +12.60%.
In the medium term (3months), MYOS's stock price should outperform the market by 7.04%. During that period the price should oscillate between -17.21% and +36.90%.Get email alerts
About MYOS RENS Technology, Inc.
MYOS RENS Technology, Inc. engages in the discovery, development, and commercialization of advanced nutrition products, functional foods, and other technologies aimed at maintaining or improving the health and performance of muscle tissue. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.62$ per share.
The book value per share is 0.50$
Three months stock forecastApril 25, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|